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Effects of Radiation Exposure From Cardiac Imaging
How Good Are the Data?
Andrew J. Einstein, MD, PHD
New York, New York
Concerns about medical exposure to ionizing radiation have become heightened in recent years as a result of
rapid growth in procedure volumes and the high radiation doses incurred from some procedures. This paper
summarizes the evidence base undergirding concerns about radiation exposure in cardiac imaging. After classi-
fying radiation effects, explaining terminology used to quantify the radiation received by patients, and describing
typical doses from cardiac imaging procedures, this paper will address the major epidemiological studies having
bearing on radiation effects at doses comparable to those received by patients undergoing cardiac imaging.
These include studies of atomic bomb survivors, nuclear industry workers, and children exposed in utero to
x-rays, all of which have evidenced increased cancer risks at low doses. Additional higher-dose epidemiological
studies of cohorts exposed to radiation in the context of medical treatment are described and found to be gener-
ally compatible with these cardiac dose–level studies, albeit with exceptions. Using risk projection models devel-
oped by the U.S. National Academies that incorporate these data and reflect several evidence-based assump-
tions, cancer risk from cardiac imaging can be estimated and compared with the benefits from imaging. Several
ongoing epidemiological studies will provide better understanding of radiation-associated cancer risks.
(J Am Coll Cardiol 2012;59:553–65) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.08.079In recent years, intensive efforts have been initiated to
reduce the ionizing radiation associated with cardiac imag-
ing. It is now routine for publications addressing cardiac
imaging to report radiation doses, and several studies have
estimated cancer risks from a variety of cardiac imaging
procedures. Concern about potential deleterious effects from
radiation, specifically cancers, abounds, in some cases even
leading to avoidance of essential procedures. As many
practitioners are unfamiliar with the terrain of the epidemi-
ological evidence base undergirding these concerns about
radiation, this paper attempts to provide a tour of this
landscape.
It is important for a discussion of the downside of cardiac
imaging to put these risks in context. Risks from testing
should not be viewed in isolation, but rather within the
context of a sober and simultaneous evaluation of the
benefits, risks, and costs of a given test in a specific clinical
context. Specifically, although imaging has its risks, it also
has indubitable benefits, in terms of improved diagnosis and
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accepted August 23, 2011.prognosis, the ability to affect medical therapy and provide
guidance for interventions, and ultimately improve patient and
societal outcomes. Although strong evidence for the latter,
which is the most important (1), has been the slowest and most
difficult to accumulate, we do have examples of studies dem-
onstrating that management strategies incorporating imaging
can improve patient-important outcomes (2), and in an envi-
ronment in which we are keenly aware of potential risks and
limits on resources, impact on outcomes is increasingly recog-
nized as the level of imaging evidence desired.
Reasons for the concern about ionizing radiation in
cardiology. Why has ionizing radiation become a concern
in cardiology? I would posit that the reason is 2-fold. First,
procedure volumes have grown tremendously. Figure 1
illustrates the growth in nuclear single-photon emission
computed tomography myocardial perfusion imaging vol-
ume, which increased by nearly 3-fold over the course of a
decade (3). Although information on cardiac computed
tomography (CT) volume is not as robust, the number of
coronary CT angiograms increased from virtually zero in the
early 2000s to several hundred thousand studies per year.
A second reason for the increasing concern is the mag-
nitude of the doses of radiation that many patients under-
going cardiac imaging procedures have received and con-
tinue to receive (Table 1). It is easy for patients undergoing
a single cardiac imaging examination to receive the amount
of radiation equivalent to 1,000 chest x-rays, a lifetime
of screening mammograms, or many years’ background
radiation.
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creased volumes and multiplies
them by high doses, the net re-
sult is a public health problem.
The National Council on Radia-
tion Protection and Measure-
ments, a congressionally char-
tered organization aimed at
ensuring the radiation safety of
the U.S. public, has performed
comprehensive reviews of radia-
tion exposure to the American population from all sources
twice over the past 3 decades, once covering the period 1980
to 1982 (4), and once for 2006 (5). The difference between
these 2 reports is striking (Fig. 2). In the earlier time period,
nonmedical radiation constituted a per capita effective dose
of 3 mSv per year, whereas medical radiation accounted for
0.53 mSv per year. Although nonmedical radiation exposure
emained basically constant over the 25-year period, medical
adiation increased about 6-fold, to 3.0 mSv per capita per year.
f note, radiation from cardiac imaging and intervention
ccounted for roughly 17% of all ionizing radiation to the
merican public from all sources (excluding radiotherapy).
ypes of radiation effects. Two fundamental terms are
used to classify types of effects from radiation: deterministic
effects and stochastic effects (6). Deterministic effects, also
alled tissue reactions, are those due to injury of a popula-
ion of cells from radiation-induced cell death or serious
alfunction. Deterministic effects characteristically only
ccur above a threshold dose, which, although varying from
ndividual to individual, is high, often only after a large
roportion of cells in a tissue have been killed by radiation.
he severity of deterministic effects commonly increases
Abbreviations
and Acronyms
BEIR  Biological Effects
of Ionizing Radiation
CT  computed
tomography
ERR  excess relative risk
LNT  Linear No-Threshold
MI  myocardial infarction
Figure 1 Growth in Nuclear Single-Photon Emission Computed
Data sources: Arlington Medical Resources (AMR), courtesy Greg Thomas, MD, an
MPI  myocardial perfusion imaging.with dose, as more cells are killed or damaged. Examples of
deterministic effects are skin and hair changes (7), cardio-
vascular disease, and cataracts. Deterministic effects typi-
cally do not occur at the levels of radiation that patients
undergoing noninvasive imaging procedures receive, al-
though there have been some widely reported examples of
patients undergoing CT angiography/perfusion studies of
the brain who received high doses causing hair loss (8).
In contrast, stochastic effects, which are the effects of
concern from imaging tests, are those for which the prob-
ability of an effect, but not its severity, depend on dose of
radiation received (6). Stochastic effects are generally caused
by radiation-induced mutations rather than by cell death.
graphy MPI Volume
Medical Division, e.g. (3).
Typical Effective Dosesof Some Sources of RadiationTable 1 Typical Effective Dosesof Some Sources of Radiation
Source
Typical
Dose (mSv)
Chest X-Rays
(Posteroanterior)
Chest x-ray (posteroanterior) 0.02 1
Chest x-ray (posteroanterior and lateral) 0.10 5
Round trip flight, New York to New Orleans 0.02 1
Backscatter scanner for airport screening 0.001 1/20
Mammogram 0.7 35
Head CT 2 100
Background radiation to public (annual) 3 150
Abdominal CT 10 500
Average annual occupational dose limit*
(ICRP) (6)
20 1,000
Dual isotope MPI or helical coronary CTA 25 1,250
Highest doses received by Fukushima
workers
250 12,500
*Average over 5-year period. Allows for up to 50 mSv in any single year.
CT  computed tomography; CTA  computed tomography angiogram; ICRP  International
ommission on Radiological Protection; MPI  myocardial perfusion imaging.Tomo
d IMV
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effects do not definitely occur at a specific dose but rather occur
with a probability that is generally thought to increase as dose
increases. Severity of a stochastic effect does not depend on the
radiation dose—the mutation occurs or it does not. The 2
common types of stochastic effects are malignancies and
heritable disease in offspring. Cancers occur after a latency
period, which evidence suggests is at least 5 to 10 years for
most solid tumors and 2 years for nonchronic lymphocytic
leukemia leukemias (radiation is not thought to cause chronic
lymphocytic leukemia) (9). Although there are significant
experimental data for heritable effects of radiation, there is no
direct evidence in humans (6).
How ionizing radiation is quantified. Two classes of terms
are used to numerically characterize ionizing radiation: doses
and risks. A dose is a measure of energy deposition in matter,
whereas a risk is the probability of a deleterious event, for
example, cancer incidence or mortality, occurring. A slew of
different types of dose-related quantities exist, resulting in
quantification that can often be ambiguous and confusing.
Figure 2 The Increasing U.S. Radiation Burden
Data from National Council on Radiation Protection and Measurements Reports 93
tive dose from cardiovascular imaging and intervention in 2006 constituted 19% o
population, and was nearly 3 times the collective dose from all medical source
NM  nuclear medicine.Doses to individual organs are typically reported as the con-centration of energy deposited per unit of matter (organ
absorbed doses), and reported in units of milligrays (mGy), a
special unit term denoting millijoules per kilogram of tissue in
this context. There are several modality-specific dose indices,
such as the dose-length product for CT and the kerma-area
product for fluoroscopy (10).
In the past few years, the type of dose reported most
commonly in the context of medical imaging is the effective
dose, a doubly weighted measure of organ absorbed doses,
weighted to reflect the type(s) of energy and the relative
radiosensitivities of each organ/tissue, summed over all
organs (6). Effective dose is typically reported using another
special unit, the millisievert (mSv), which also denotes
millijoules per kilogram of tissue, and is commonly esti-
mated in cardiac imaging by multiplying a modality-specific
dose index by a standard conversion (“k”) factor (11).
However, since organ doses used in the definition of
effective dose are those in a nonobese, gender-averaged
“reference person,” and tissue weighting factors are rounded
values reflecting multiple factors such as radiation-related
nd 160 (5), from all medical sources except radiation therapy. Note that collec-
ollective effective dose of radiation from all nonradiotherapy sources to the U.S.
e early 1980s. CT  computed tomography; Fluoro  fluoroscopy;(4) a
f the c
s in thrisk and lethality of cancer and effect on quality of life,
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is not a measure that is designed to characterize radiation
exposure to an individual patient from an individual study.
Rather, it is designed to approximately characterize the
radiation burden to a typical individual from a given
procedure and protocol. As such, although widely done in
the literature, it is “off-label” and formally improper to refer
to the effective dose from a specific study performed on a
specific patient.
Radiation dose to cardiac imaging patients. Typical ef-
fective doses from cardiac imaging studies are illustrated in
Figure 3 (12). Such point estimates, however, fail to reflect
the tremendous variability, between sites and between
studies at a given site, that exists in dose indices for a given
procedure (13). For example, in the PROTECTION I
(Prospective Multicenter Study on Radiation Dose Esti-
mates of Cardiac CT Angiography in Daily Practice I)
study evaluating radiation dose from 50 sites worldwide,
site-specific median dose–length products ranged 7-fold,
and were over 2,000 mGy·cm, corresponding to a median
effective dose of at least 30 mSv, in the highest-dose sites
(14). Even using state-of-the-art technology that permits
“sub-millisievert” scanning, some patients may still receive
substantial amounts of radiation (Fig. 4) (15). In nuclear
cardiology, dual isotope protocols may be associated with
effective doses typically over 25 mSv. Moreover, many
patients undergoing a single cardiac imaging study will
undergo many procedures involving ionizing radiation. In 1
series of 1,097 patients undergoing index myocardial perfu-
sion imaging, the typical patient underwent a median of 14
additional procedures involving ionizing radiation over a
20-year period, thereby receiving a cumulative estimated
effective dose of 64 mSv (16).
Evidence of cancer risk at levels of radiation commonly
received by cardiac imaging patients. Thus, effective
doses from cardiac imaging procedures on the order of up to
50 mSv are not uncommon in selected patient populations.
Figure 3 Typical Effective Doses From Cardiac Imaging Proced
Adapted from Einstein (12) with permission from BMJ Publishing Group Ltd. PET  poIn evaluating epidemiological data relating ionizing radia-
tion exposure to cancer risk for generalization to populations
of patients exposed to cardiac imaging procedures, the ideal
study would be characterized by a number of features. It
would involve exposure of primarily adult patients, who
constitute the bulk of cardiac imaging patients, to very-low-
dose (50 mSv) x-rays or gamma-rays from an acute, not
chronic, medical exposure. The ideal study would be a
cohort study, rather than a case-control study, for which
there may be susceptibility to recall bias and an inability to
adjust for all confounders, and have adequate statistical
power to detect an increase in cancer incidence in the
exposed cohort. A real challenge is posed by this latter
consideration, since radiation is a weak carcinogen, and
background cancer rates in the population are so high
(lifetime risk of approximately 42% [9]). The National
Academies (17) have estimated the sample size required to
detect a significant increase in cancer mortality in a cohort
exposed to a specific dose of radiation to an organ. For doses
between 5 and 50 mGy, these figures range between about
100,000 and 10 million (Fig. 5 [18]). The cost of perform-
ing such a study, with long follow-up, is very high, and as
such there are very limited data from such low-dose cohorts.
The 3 major very-low-dose epidemiological studies have
evaluated Japanese atomic bomb survivors, nuclear industry
workers, and children exposed to x-rays in utero. None
involves exposure to cardiac imaging procedures or to adult
medical imaging procedures, and none meets all of the
characteristics of the ideal study, but their results uniformly,
and statistically significantly, suggest an increase in cancer
risk at radiation doses commonly received by cardiac imag-
ing patients (Table 2).
VERY-LOW-DOSE STUDIES. The Life Span Study (LSS)
represents an extensive undertaking on the part of the
Japanese Ministry of Health, Labor, and Welfare and the
U.S. Department of Energy and National Academy of
emission tomography; other abbreviations as in Figures 1 and 2.ures
sitron
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radiation exposure and cancer risk in survivors of the atomic
bombings in Hiroshima and Nagasaki. It is one of the few
radiation effects studies comprised of a basically healthy
Figure 4 Coronary CT Angiogram Performed in a 64-Year-Old O
The scanner used is most commonly operated using a tube voltage of 100 kVp an
dow during diastole, resulting in a dose-length product (DLP) for angiography of 6
was operated at 120 kVp and a scan mode that leaves the x-ray tube on througho
detected. The study was diagnostic and excluded coronary artery disease (bottom
left); however the x-ray tube remained on for over 3 s, and the total DLP was 2,
would correspond to an estimated effective dose of 78 mSv using an updated c
Figure 5
Sample Size of a Cohort That Would Be Required
to Detect a Significant Increase in
Cancer Mortality in That Cohort
Data show exposure to different radiation doses and assume lifetime follow-up.
Reproduced with permission from Brenner et al. (18), based on National Research
Council 1995 (17). Copyright 2003 National Academy of Sciences, U.S.A.population of both genders and all ages exposed to a wide
range of radiation doses, and presently has analyzed over 40
years of follow-up data to assess risks of radiation-
attributable cancer incidence (19). Survivor-specific dosim-
etry estimates have been refined multiple times, and reflect
numerous factors, including distance from the hypocenter,
information on acute effects, such as burns and epilation,
and shielding history, including detailed information on
location, position, and surroundings at the time of the
Man With Atypical Chest Pain and Frequent Ventricular Ectopy
le-heartbeat volume scanning with x-rays delivered only during a 400-ms win-
50 mGy·cm. Here, because of the patient’s habitus and ectopy, the scanner
cardiac cycle and continues image acquisition in subsequent beats if ectopy is
despite 3 out of 4 heartbeats being premature ventricular contractions (top
Gy·cm (top right). In a population of patients undergoing similar scans, this
ion factor (15).
Characteristics of EpidemiologicalStudies Addre sing Cancer Risk AssociatedWith Very-Low-Dose (<50 mSv) Ionizing Radiation
Table 2
Characteristics of Epidemiologic l
Studies Addressing Cancer Risk Associated
With Very-Low-Dose (<50 mSv) Ionizing Radiation
Population
Atomic Bomb
Survivors
Nuclear
Workers
In Utero
X-Ray
Primary study Life Span
Study
15-Country
Study
Oxford Survey of
Childhood Cancer
Study characteristics
Adults ✓ ✓
Medical ✓
X-ray or gamma-ray only ✓
50 mSv ✓ ✓ ✓
Acute exposure ✓ ✓
Cohort study ✓ ✓
Adequate power ✓ ✓ ✓
Sample size 120,321 407,391 30,552
Typical dose (mSv/mGy) 29 19.4 10
Excess relative risk of cancer* 0.02 0.02 0.39bese
d sing
0 to 1
ut the
left),
500 m
onversAll excess relative risks are statistically significant. *At typical dose.
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Nagasaki residents into “exposed” and “nonexposed” co-
horts, depending on whether radiation dose to the colon was
5 or 5 mGy (comparable to 5 mSv effective dose since
exposure was basically uniform throughout survivors’ bodies
and most exposure was from gamma-rays). Among the
subset of the exposed cohort alive without cancer on January 1,
1958, and with doses of no more than 100 mSv, constituting
27,789 individuals typically between 2,000 and 3,000 yards
of the hypocenter, mean dose was 29 mSv, and 4,406 solid
cancers were observed between 1958 and 1998 (Fig. 6). The
number of solid cancers expected, based on rates in the
nonexposed cohort, was 4,325, and thus there were 81 (2%)
excess cancers attributed to radiation, that is, an excess
relative risk (ERR) of 0.02 (19). Rates of excess common
cancers were 2.0% for colon, 1.3% for liver, 2.3% for lung,
4.3% for female breast, 1.8% for ovary, 0.4% for prostate,
3.1% for bladder, 0.4% for kidney, 3.9% for thyroid, and
1.9% for nervous system including brain.
The 15-Country Study of Cancer Risk in Radiation
Workers in the Nuclear Industry (21,22) involved 5.2
million person-years of follow-up of workers at 154 facili-
ties, 90% of whom received facility- or national registry-
recorded doses of 50 mSv from chronic occupational
exposure. A total of 24,158 workers died during follow-up,
including 196 from leukemia and 6,519 from all other
cancers, for which ERR was 0.97 cancers/Sv (95% confi-
dence interval: 0.14 to 1.97). Testing for heterogeneity
provided no evidence for differences in risk between cohorts,
countries, or groups of facilities, although the point estimate
Figure 6 Simplified Hiroshima Atomic Bomb Dosimetry
Map of Hiroshima is overlaid with colors reflecting typical patient doses at distanc
at least 100 mGy (effective dose at least 100 mSv), and the orange ring constitu
spond to the “Exposed” cohort. The green area constitutes the area with typical e
cantly more cancers have been observed in the orange ring than would be expect
The actual current dosimetry system, updated in 2002, reflects several factors in
acute effects such as burns and epilation. Hiroshima map without overlays have b
http://www.atomicarchive.com/Maps/HiroshimaMap.shtml.for ERR was highest for Canada and when Canadian
workers were excluded, ERR was no longer significantly
different from 0 (0.58, 0.22 to 1.55). Risk estimates
increased with increasing lag period, from 0.76 (0.07 to
1.59) with 5-year lag to 1.68 (0.22 to 3.48) with 20-year lag.
One limitation of this study is that data were not available
to adjust directly for possible confounders due to smoking,
diet, and occupational exposures, although these were par-
tially addressed indirectly by adjustment for socioeconomic
status. ERR estimates were higher than, but statistically
compatible with, those from the Life Span Study, which
excluded survivors dying or developing cancer in the first 13
years between 1945 and 1958; however, these elevated ERR
estimates have been observed to be sensitive to the impact of
missing dosimetry at 1 Canadian facility. Methodological
concerns such as the incomplete dosimetry data, possible
confounders, and inclusion criteria selected have engen-
dered controversy about the 15-Country Study’s findings
and interpretation (23).
The third large population evaluated after very-low-dose
radiation exposure is children exposed to x-rays in utero.
The largest such study was the Oxford Survey of Childhood
Cancers, a case-control study of all children dying of cancer
in the United Kingdom under age 16 years and matched
controls. Exposure status was determined based on maternal
recollection and was largely confirmed by prenatal records
(24,25). The smaller sample size in this study was counter-
balanced by the case-control design and increased radiation
sensitivity of the population exposed before birth, and ERR
for in utero exposure was 0.39 (0.30, 0.49). Several similar
hypocenter. The red circle constitutes the area in which typical colon dose was
area with typical effective dose of 5 to 100 mSv; together, these roughly corre-
e dose of 5 mSv, roughly corresponding to the “Nonexposed” cohort. Signifi-
ed on rates in the green area, an excess that is attributed to ionizing radiation.
n to distance from the hypocenter, including shielding history and information on
produced with permission from the AtomicArchive.com website:e from
tes the
ffectiv
ed bas
additio
een re
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similar findings. This entire literature was reviewed by
Richard Wakefield and Sir Richard Doll, arguably the
leading epidemiologist of the 20th century, who demon-
strated the connection between smoking and lung cancer
and heart disease. They concluded that “a causal explanation
is supported by evidence. . . radiation doses of the order of
10 mGy received by the fetus in utero produce a consequent
increase in the risk of childhood cancer” (26).
SMALLER, HIGHER-DOSE STUDIES OF MEDICALLY EXPOSED
COHORTS. Although the 3 very-low-dose studies men-
tioned in the previous text all found increased cancer risk at
doses typical for some cardiac imaging patients, they did not
involve exposure of adult patients to medical radiation.
Although the putative mechanism of tumorigenesis in these
studies is the same as that which could occur in cardiac
patients receiving radiation, namely causality of DNA dam-
age via an ionization event, subsequent genetic mutations,
or chromosomal mutations from DNA damage misrepair,
and ultimately the development of cancer (9), and thus this
evidence is highly suggestive that cardiac procedures have
the possibility of causing cancer, many practitioners would
be more comfortable drawing such a conclusion from
epidemiological data deriving from radiation exposure sce-
narios more akin to cardiac imaging and intervention.
Indeed, there are a number of patient populations for which
we have strong epidemiological data relating medical radi-
ation to cancer risk; unfortunately the typical cumulative
radiation doses received by individuals in these populations
are considerably higher than those received by many of our
cardiology patients, a necessary condition to enable ade-
quate statistical power at smaller sample sizes.
Until the 1960s, radiation therapy was a relatively com-
mon treatment for numerous benign diseases, and consid-
erable radioepidemiological data exists from these patients.
Table 3 summarizes studies evaluating thyroid cancer risk
after childhood radiotherapy for a variety of conditions
(27–38). Although thyroid dose received by patients in these
Epidemiological Studies of Thyroid CancerAfter Childhood RadiotherapyTable 3 Epidemi logical Studies of ThyroidAfter Childhood Radiotherapy
Study
Mean Dos
(Gy)
Childhood cancer (28) 12.0
Tuberculosis, adenitis (29) 8.2
Chicago head and neck (30) 4.5
Thymus adenitis (31) 2.9
Rochester enlarged thymus (32) 1.4
Michael Reese enlarged tonsils (33) 0.6
Stockholm hemangioma (34) 0.3
Lymphoid hyperplasia (35) 0.2
Israel tinea capitis (36) 0.1
New York tinea capitis (37) 0.1
Gotenburg hemangioma (38) 0.1Ranges in parentheses denote 95% confidence intervals. Reproduced with perm
Abbreviations as in Table 2.studies spanned 2 orders of magnitude, with mean doses as
low as 100 mGy, excess risk per Gy received is generally
compatible among these many studies, and with only a
single exception, always statistically significantly 0. These
studies evidenced a linear dose-response relationship and no
lower threshold below which there was no increased risk,
that is, consonance with the Linear No-Threshold (LNT)
model (27). Similarly, numerous cohorts of patients under-
going medical radiation have been studied for excess breast
cancers. These include patients in Massachusetts (39,40)
and Canada (41) receiving repeated chest fluoroscopies as
part of pneumothorax therapy for tuberculosis, patients in
Gothenburg (38) and Stockholm (42) receiving gamma-rays
for skin hemangioma, and patients receiving therapeutic x-rays
for post-partum mastitis in New York (43), benign breast
disease in Sweden (44), and thymic enlargement in Rochester,
NY (45). Breast doses to subjects in these studies ranged from
20 mGy to 35 Gy, with mean doses ranging from 170 mGy to
5.8 Gy. Excess cancer risk was noted in each of these cohorts,
and risk generally increased with attained age until about age
50 years at which point it plateaued in several studies (Fig. 7).
The authors of a systematic review of most of these data (46)
concluded that excess risk of breast cancer depends linearly on
dose with a downturn at high doses, where cell death may
occur, and that risk is similar between acute and fractionated
high-dose-rate exposures, but lower with protracted low-dose
rate exposures, although others have alternatively interpreted
some of this data to conclude that fractionation also somewhat
reduces risk (47). These studies were also generally compatible
with the Life Span Study in terms of excess cancer rates
(Fig. 7) (40,46), although there was some variation in rates
between studies, leading the authors of the systematic
review to point out that “no simple unified summary model
adequately describes the excess risks in all groups” (46).
In addition to the studies evaluating thyroid and breast
cancer, several other studies have evaluated risks of individ-
ual cancers from radiation to medically exposed cohorts. For
the most part, these studies demonstrate excess cancer rates
er
ERR/Gy
EAR
(104 Person-Year·Gy)1
4.5 (3.16.4) 0.4 (0.20.5)
37.0 (1672) 7.7 (3.315)
12.0 (6.620) 3.5 (2.05.9)
4.5 (2.77.0) 1.2 (0.71.8)
9.5 (6.913) 3.0 (2.24.0)
3.0 (2.63.5) 38.0 (3243)
4.9 (1.310) 0.9 (0.21.9)
5.9 (1.812) 9.1 (2.718)
34.0 (2347) 13.0 (9.018)
7.7 (060) 1.3 (010)
7.5 (0.418) 1.6 (0.093.9)Canc
eission of Wolters Kluwer Health from Ron (27).
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However, in a few cases, no increased risk of individual
cancers was demonstrated. In a study of 15,577 U.K.
ankylosing spondylitis patients diagnosed between 1935 and
1957, patients receiving radiotherapy had a significant
excess cancer mortality risk of 0.30 (0.24 to 0.35) above that
expected from national rates, and significant increases indi-
vidually for many, but not all organs (49). In both the
Massachusetts (54) and Canadian (53) chest fluoroscopy
cohorts, despite significantly increased rates of breast cancer
Figure 7 Excess Breast Cancer Rate per WY·Gy
Using Excess Absolute Risk Models
Comparison of Life Span Study (LSS) of Japanese atomic bomb survivors to
medically exposed cohorts. THY denotes thymic enlargement cohort (45); BBD
benign breast disease (44); HMG, HMS hemangioma in Gothenberg (38) and
Stockholm (42), Sweden, respectively; and TBO, TBX original (41) and
extended (40) Massachusetts tuberculosis cohorts, respectively. Reproduced
with permission of the Radiation Research Society–BioOne, from Preston et al.
(46). WY  woman-years.
Comparison of Estimated ERR/Gy Between Selected Medical StudTable 4 Comparison of Estimated ERR/Gy Between Selected M
Cancer
Site Medical Study Sex
Mean O
Stomach Cervical cancer (48) Females
Stomach Ankylosing spondylitis (49) Males (83%)
Colon Uterine bleeding (U.S.) (50) Females
Colon Uterine bleeding (U.K.) (51) Females
Lung Peptic ulcer (52) Males (80%)
Lung Fluoroscopy (53) Males
Lung Fluoroscopy (53) Females
Prostate Ankylosing spondylitis (49) Males (83%)
Bladder Ankylosing spondylitis (49) Males (83%)
Data are for organs other than breast and thyroid. To be included here, sites had to meet the followi
estimates of the excess relative risk (ERR)/Gy; 3) the mean dose to the organ of interest was 4 G
are sex-specific estimates from BEIR (Biological Effects of Ionizing Radiation) VII Table 12-3 (for the sex i
permission from the National Academies Press, BEIR VII Table 12-11 (9). Copyright 2006, National Acadthat were consistent with Life Span Study data and in-
creased linearly with dose (40,55), lung cancer risk was not
increased. Various approaches have been offered to account
for this discrepancy, including the amelioration of excess
lung cancer risk by fractionation (9,53,54), and the modi-
fication of radiation-related risk in organs directly affected
by disease, such as tuberculous lungs (9,53).
QUEBEC POST-MI STUDY. There is 1 recent study evaluating
a cohort that received both very-low doses and radiation
specifically from cardiac imaging and interventional proce-
dures (56). This study used a Quebec hospital discharge
summary database to create a retrospective cohort of 82,861
patients with acute myocardial infarction (MI) between
April 1996 and March 2006 with no cancer diagnosis in the
year before and year after this hospital admission. This data
was linked to a health insurance database to identify billing
codes for procedures performed involving ionizing radia-
tion. No patient-specific dosimetry or organ dosimetry was
estimated, but rather a typical effective dose was assigned for
each of 4 specific cardiac procedures: myocardial perfusion
imaging (15.6 mSv), diagnostic cardiac catheterization (7.0
mSv), percutaneous coronary intervention (15.0 mSv), and
resting ventriculography (7.8 mSv). Cancers were identified
beginning 1 year after MI based on International Classifi-
cation of Diseases codes, and there was a mean follow-up of
5.0 years. The authors found that radiation exposure from
cardiac procedures was 5.3 mSv/patient-year, of which 40%
was from percutaneous coronary intervention, 30% from myo-
cardial perfusion imaging, and 24% from diagnostic catheter-
ization, with 84% of radiation in the first year post-MI. Mean
exposure from noncardiac procedures was 1.6 mSv. There were
12,020 incident cancers in the cohort. In a time-dependent
Cox proportional hazards model adjusting for age, sex, and
exposure to low-dose ionizing radiation from noncardiac pro-
cedures, cumulative estimated dose from cardiac procedures
was an independent predictor of incident cancer (hazard ratio:
1.003 per mSv, 95% confidence interval: 1.002 to 1.004).
Thus, for every 10 mSv of radiation, the authors estimated a
nd the LSS of Japanese Atomic Bomb Survivorsal Studies and the LSS of Japanese Atomic Bomb Survivors
ose, Exposed
Cases, N
ERR/Gy Based on
Medical Study
(95% CI)
Comparable ERR/Gy
From LSS Cohort
(95% CI)
348 0.54 (0.05–1.5) 0.48 (0.31–0.73)
127 0.004 (0–0.05) 0.21 (0.11–0.40)
75 0.51 (0–5.6) 0.43 (0.19–0.96)
47 0.13 (0.01–0.26) 0.43 (0.19–0.96)
125 0.24 (0.07–0.44) 0.32 (0.15–0.70)
347 0.02 (0–0.11) 0.32 (0.15–0.70)
108 0.06 (0–0.07) 1.40 (0.94–2.1)
88 0.14 (0.02–0.28) 0.12 (0–0.69)
71 0.24 (0.09–0.41) 0.50 (0.18–1.4)
ria: 1) the BEIR VII committee provided cancer risk estimates; 2) the study investigators presented
4) the estimate was based on at least 30 exposed cases. For the Life Span Study (LSS), estimatesies aedic
rgan D
Gy
2
2.5
1.3
3.2
1.8
1.0
1.0
1.5
1.5
ng crite
y; andndicated in column 3) and are for exposure at age 30 years at attained age 60. Reproduced with
emy of Sciences.
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mean 5-year follow-up, suggesting that in post-MI patients
“exposure to low-dose ionizing radiation directly affects the
likelihood of cancer.”
Although the conclusions of this study are provocative,
several highly unusual findings and methodological concerns
have been pointed out, and many experts believe that until
further analyses are presented, the study findings must be
regarded as preliminary (57). The effect noted in the study
is an order of magnitude greater than in other epidemi-
ological studies of adult radiation exposure. Cancer
incidence in the cohort was at least 2 times the expected
incidence in the Canadian public. Solid tumors (92% of
the cancers in the cohort) typically occur only after a 5-
to 10-year latency period after radiation exposure (9), yet
ean follow-up here was only 5 years. Confounders such as
moking were not accounted for. Analysis was performed
sing an estimated effective dose, and there was no study of the
elationship between organ dose and organ-specific cancer.
stimated effective doses were those for a typical dose from a
rocedure and did not reflect radiation received by the indi-
idual patient, for example, the 15.6 mSv estimate for all
yocardial perfusion imaging exams is a figure reflecting a
.S. prevalence–weighted average of typical effective doses
rom standard protocols ranging from stress-only tetrofos-
in (7.2 mSv) to thallium rest-reinjection (30.1 mSv) (58).
hus, in the absence of further analyses, including demon-
tration of association between site-specific cancers and
rgan-specific doses, explanation of the high baseline cancer
ncidence, and presentation of cancers by latency period, the
ossibility remains that the study’s findings represent a
purious association unrelated to cancer causality.
ONGOING STUDIES. In addition to the completed studies
resented in the previous text, there are a number of
ngoing large epidemiological studies of very-low-dose
edical radiation that will further refine our understanding
f radiation-associated cancer risk. These mostly focus on
hildren who underwent computed tomography. The in-
reased sensitivity of children to radiation-induced cancer
nables such studies to be performed with much smaller
ample sizes than in adults. The first of these studies,
xpected to report initial results in the next year, is evalu-
ting a cohort currently of about 250,000 individuals under
ge 22 years in the United Kingdom, and includes
ndividual-level outcome data, dosimetric modeling reflect-
ng patient information collected from radiology depart-
ents and scanner- and protocol-specific information
59,60). Additional similar studies are being conducted,
ncluding in Ontario, Canada (275,000 children), Austra-
ia (150,000), Israel, and several European countries, and
he World Heath Organization’s International Agency for
esearch on Cancer is coordinating a European collabora-
ive study, incorporating over a million children, called
PI-CT (Epidemiological Study to Quantify Risks for
aediatric Computerized Tomography and to Optimise toses). Another study in the United Kingdom, just begin-
ing, will evaluate cancers in a cohort of children who
nderwent interventional cardiology procedures.
pplying epidemiological data to estimating cancer risk
rom cardiac imaging. Given the absence of direct evi-
ence from cardiac imaging, current risk estimates for
ardiac imaging procedures are in fact projections from the
vailable epidemiological evidence. This evidence base has
een comprehensively reviewed several times since the
950s by a series of expert committees on the Biological
ffects of Ionizing (formerly Atomic) Radiation, now
nown by the acronym BEIR, that have been convened by
he U.S. National Academies. Their most recent report,
EIR VII, was released in 2005, and reflected all of the
forementioned literature that was then available (the 15-
ountry Study became available only after the draft report
ad been reviewed, and the Quebec Post-MI study had not
een conducted) (9). The BEIR VII committee’s compre-
ensive review led them to conclude, with caveats and like
he other major U.S. and international advisory organiza-
ions, that the LNT model best fits the currently available
ata for purposes of radiation protection (61). Thus, despite
idespread misunderstanding to the contrary, LNT is not
egarded as reflecting a conservative approach to estimating
isk from low-dose radiation exposure (i.e., an upper esti-
ate of risk), but rather the best simple model given the
urrently available data.
In particular, BEIR VII devoted an appendix to address-
ng the evidence relating to the concept of “hormesis,”
hich posits that low doses of radiation provide a beneficial
ealth effect by means of adaptive protection, stimulating
NA damage prevention and repair as well as immune
timulation (62). This analysis concluded that it is unwar-
anted to assume that any such hormetic effects from
ow-dose radiation have significant health benefits to hu-
ans that outweigh radiation’s detrimental effects (9).
BEIR VII developed LNT-assuming risk models for
ancer incidence and mortality, applicable to the general
.S. population, that can be used in conjunction with
stimates of organ doses to estimate cancer risk from specific
edical exposures. These models are largely based on data
rom the Life Span Study, although the pooled breast cancer
odel from the systematic review discussed in the previous
ext (46), and a thyroid cancer model (63) based on several
f the medical studies tabulated in the previous text (63), are
ncorporated. BEIR VII risk projection models have been
pplied to several cardiac imaging scenarios to estimate
ancer risk to patients and populations. My colleagues and I
pplied BEIR VII models to estimation of cancer risk from
oronary CT angiography using a helical protocol, finding
adiation-attributable risks that varied widely depending on
atient age, gender, and scan protocol (Fig. 8), which were
oughly 1 in 3,000 in older men but approached 1% in
oung women (64). This analysis was subsequently repeated
y Huang et al. (65) after the introduction of prospectively
riggered CT angiography, demonstrating patterns of risk
562 Einstein JACC Vol. 59, No. 6, 2012
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helical scanning, but with absolute risks reduced roughly
proportionally to the 80% reduction in dose. Kim et al.
(66) have applied BEIR VII methodology to screening with
coronary artery calcium scoring, finding that every-5-year
screening as advocated by the Screening for Heart Attack
Prevention and Education (SHAPE) guidelines would be
associated with an estimated 42 cancers per 100,000 men
screened and 62 per 100,000 women, estimates that can be
compared with potential benefits from screening. Ber-
rington de Gonzalez et al. (67) have applied BEIR meth-
odology to estimating cancer risks from myocardial perfu-
sion imaging, demonstrating, analogously to Huang et al.,
that reduced-dose nuclear stress testing protocols are asso-
ciated with reduced estimated cancer risks.
Thus, BEIR VII risk projection models offer a practical
tool to estimate radiation risk from cardiac imaging proce-
dures, to be considered in the context of an analysis of
benefits, risks, and costs. Nevertheless, even beyond the
LNT assumption, several assumptions underlie these mod-
els that render their risk projections approximate values with
associated uncertainty. These models transport data from a
healthy Japanese to a healthy U.S. population, and assump-
tions need to be made as to how to account for differences
in baseline cancer rates. Application of BEIR models to
Figure 8 Estimated Risk of Cancer Incidence Attributable to C
(Top) Estimates from Einstein et al. (64). Copyright 2007 American Medical Assoc
permission of the British Institute of Radiology), which are comparable to those of
protocol. All estimates are for retrospectively gated helical scanning except for es
lifetime attributable risk.populations with decreased life expectancy in comparison tothe general U.S. population, as is the case for many
populations of patients undergoing cardiac imaging and
intervention, will result in overestimates of radiation-
attributable cancer risk, and consequently estimates of the
total number of cancers attributable to such procedures may
also be overestimates. Although methods have been intro-
duced to adjust risks based on clinically determined life
tables (Fig. 9) (68), such life tables are not available for
many populations of interest. X-rays used in medical imag-
ing may have differences in tumorigenic potential in com-
parison to the high-energy gamma-rays from atomic bombs
(69), and risk models need to incorporate a choice as to how
to approach this potential difference. There is an assumed
factor used to extrapolate data from acute high-dose to
low-dose exposures, the selection of which is a matter of
some debate. Assumptions are made as to the forms and
sizes of dose uncertainties (9).
Each assumption made was based on exhaustive consid-
eration of all available biophysical as well as epidemiological
evidence by a team of experts who are world-class scholars
of radiation biology, physics, and epidemiology, and who
were accountable to multiple feedback mechanisms. Al-
though it has become popular in some cardiovascular circles
to minimize the potential problem of ionizing radiation
exposure by emphasizing the uncertainty inherent in these
ry CT Angiogram
. All rights reserved. (Bottom) Estimates from Huang et al. (65) (reproduced with
in et al. (64) and demonstrate markedly lower risk with prospectively triggered
s labeled prospectively in the bottom panel. bpm  beats per minute; LAR orona
iation
Einste
timateassumptions, foremost among them the LNT model, I
c
t
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in the National Academies’ BEIR VII committee pertinent
to addressing these issues exceeds that in our cardiology
community. Although BEIR VII models most admittedly
estimate phantom cancers in phantom patients, and rest on
evidence-based assumptions that may at some future date be
demonstrated to be erroneous, they provide the best frame-
work available today for estimating the radiation risks that
may offset in part the multitudinous benefits of cardiac
imaging and intervention.
Effects of radiation exposure from cardiac imaging: how
good are the data? In summary, no strong data currently
relate ionizing radiation specifically from cardiac imaging to
increased risks of cancer. Nevertheless, several landmark epi-
demiological studies involving similar levels of radiation expo-
sure all show increased cancer risk, and allow risk projection.
All low-dose and most high-dose studies show increasing
cancer risk with increasing radiation dose, although there are a
few exceptions, notably studies of lung cancer in cohorts who
underwent repeated fluoroscopy as part of pneumothorax
therapy for tuberculosis. BEIR VII risk projection models,
although based on multiple assumptions, best fit the available
data and can be used to estimate cancer risks associated with
cardiac imaging. Nontrivial risks that have been described in
some scenarios underscore the importance of justification of all
studies involving ionizing radiation, a goal towards which
appropriate use criteria (70,71) and guidelines (72) can serve as
valuable tools. The reduction in estimated risk that has been
shown to parallel reduction in dose underscores the importance
of dose optimization using the ALARA (As Low As Reason-
ably Achievable) principle (6), which to implement necessitates
ontinual improvement in protocols, equipment, and training
Figure 9
Reduction of Cancer Risk From Coronary CT
Angiography in Post-CABG Patients in Comparison
to Healthy Patients
Shown are data from post-coronary artery bypass graft (CABG) patients in com-
parison to healthy patients. Error bars show 95% confidence intervals on the
estimated risk ratio. Reproduced with permission of the Radiological Society of
North America from Brenner et al. (68). CT  computed tomography.o ensure best practice. Several important ongoing epidemio-logical studies involving over a million individuals exposed to
medical radiation will provide us with a fuller picture as to the
true effects of radiation exposure from cardiac imaging.
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